|
1
|
Heimbach JK, Kulik LM, Finn RS, Sirlin CB,
Abecassis MM, Roberts LR, Zhu AX, Murad MH and Marrero JA: AASLD
guidelines for the treatment of hepatocellular carcinoma.
Hepatology. 67:358–380. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bertuccio P, Turati F, Carioli G,
Rodriguez T, La Vecchia C, Malvezzi M and Negri E: Global trends
and predictions in hepatocellular carcinoma mortality. J Hepatol.
67:302–309. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maucort Boulch D, De Martel C, Franceschi
S and Plummer M: Fraction and incidence of liver cancer
attributable to hepatitis B and C viruses worldwide. Int J Cancer.
142:2471–2477. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi J, Han S, Kim N and Lim YS:
Increasing burden of liver cancer despite extensive use of
antiviral agents in a hepatitis B virus-endemic population.
Hepatology. 66:1454–1463. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu H, Yang C, Lu W and Zeng Y: Prognostic
significance of glypican-3 expression in hepatocellular carcinoma.
Medicine (Baltimore). 97:e97022018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Watanabe R, Inoue N, Westfall B, Taron CH,
Orlean P, Takeda J and Kinoshita T: The first step of
glycosylphosphatidylinositol biosynthesis is mediated by a complex
of PIG-A, PIG-H, PIG-C and GPI1. EMBO J. 17:877–885. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Edvardson S, Murakami Y, Nguyen TT,
Shahrour M, St-Denis A, Shaag A, Damseh N, Le Deist F, Bryceson Y,
Abu-Libdeh B, et al: Mutations in the phosphatidylinositol glycan C
(PIGC) gene are associated with epilepsy and intellectual
disability. J Med Genet. 54:196–201. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jaeken J and Péanne R: What is new in CDG?
J Inherit Metab Dis. 40:569–586. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schleinitz D, Klöting N, Lindgren CM,
Breitfeld J, Dietrich A, Schön MR, Lohmann T, Dreßler M, Stumvoll
M, Mccarthy MI, et al: Fat depot-specific mRNA expression of novel
loci associated with waist-hip ratio. Int J Obes (Lond).
38:120–125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang L, Gao Z, Hu L, Wu G, Yang X, Zhang
L, Zhu Y, Wong BS, Xin W, Sy MS and Li C:
Glycosylphosphatidylinositol anchor modification machinery
deficiency is responsible for the formation of pro-prion protein
(PrP) in BxPC-3 protein and increases cancer cell motility. J Biol
Chem. 291:3905–3917. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim N, Park WY, Kim JM, Park JH, Kim JS,
Jung HC and Song IS: Gene expression of AGS cells stimulated with
released proteins by Helicobacter pylori. J Gastroen
Hepatol. 23:643–651. 2008. View Article : Google Scholar
|
|
13
|
Kawakami F, Sircar K, Rodriguez-Canales J,
Fellman BM, Urbauer DL, Tamboli P, Tannir NM, Jonasch E, Wistuba
II, Wood CG, et al: Programmed cell death ligand 1 and
tumor-infiltrating lymphocyte status in patients with renal cell
carcinoma and sarcomatoid dedifferentiation. Cancer. 123:4823–4831.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cao Y, Song J, Chen J, Xiao J, Ni J and Wu
C: Overexpression of NEK3 is associated with poor prognosis in
patients with gastric cancer. Medicine (Baltimore). 97:e96302018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tai CJ, Su TC, Jiang MC, Chen HC, Shen SC,
Lee WR, Liao CF, Chen YC, Lin SH, Li LT, et al: Correlations
between cytoplasmic CSE1L in neoplastic colorectal glands and depth
of tumor penetration and cancer stage. J Transl Med. 11:292013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Inoue N, Watanabe R, Takeda J and
Kinoshita T: PIG-C, one of the three human genes involved in the
first step of glycosylphosphatidylinositol biosynthesis is a
homologue of Saccharomyces cerevisiae GPI2. Biochem Biophys Res
Commun. 226:193–199. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shamseldin HE, Tulbah M, Kurdi W, Nemer M,
Alsahan N, Al Mardawi E, Khalifa O, Hashem A, Kurdi A, Babay Z, et
al: Identification of embryonic lethal genes in humans by
autozygosity mapping and exome sequencing in consanguineous
families. Genome Biol. 16:1162015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leidich SD, Kostova Z, Latek RR, Costello
LC, Drapp DA, Gray W, Fassler JS and Orlean P:
Temperature-sensitive yeast GPI anchoring mutants gpi2 and gpi3 are
defective in the synthesis of N-acetylglucosaminyl
phosphatidylinositol. Cloning of the GPI2 gene. J Biol Chem.
270:13029–13035. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kinoshita T and Fujita M: Biosynthesis of
GPI-anchored proteins: Special emphasis on GPI lipid remodeling. J
Lipid Res. 57:6–24. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lakhan SE, Sabharanjak S and De A:
Endocytosis of glycosylphosphatidylinositol-anchored proteins. J
Biomed Sci. 16:932009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu B, Bell AW, Paranjpe S, Bowen WC,
Khillan JS, Luo JH, Mars WM and Michalopoulos GK: Suppression of
liver regeneration and hepatocyte proliferation in
hepatocyte-targeted glypican 3 transgenic mice. Hepatology.
52:1060–1067. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Grozdanov PN, Yovchev MI and Dabeva MD:
The oncofetal protein glypican-3 is a novel marker of hepatic
progenitor/oval cells. Lab Invest. 86:1272–1284. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakakido M, Tamura K, Chung S, Ueda K,
Fujii R, Kiyotani K and Nakamura Y: Phosphatidylinositol glycan
anchor biosynthesis, class X containing complex promotes cancer
cell proliferation through suppression of EHD2 and ZIC1, putative
tumor suppressors. Int J Oncol. 49:868–876. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ohtsuka M, Yamamoto H, Masuzawa T,
Takahashi H, Uemura M, Haraguchi N, Nishimura J, Hata T, Yamasaki
M, Miyata H, et al: C4.4A expression is associated with a poor
prognosis of esophageal squamous cell carcinoma. Ann Surg Oncol.
20:2699–2705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thapa N, Tan X, Choi S, Lambert PF,
Rapraeger AC and Anderson RA: The hidden conundrum of
phosphoinositide signaling in cancer. Trends Cancer. 2:378–390.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thorpe LM, Yuzugullu H and Zhao JJ: PI3K
in cancer: Divergent roles of isoforms, modes of activation and
therapeutic targeting. Nat Rev Cancer. 15:7–24. 2014. View Article : Google Scholar
|
|
28
|
Vanhaesebroeck B, Stephens L and Hawkins
P: PI3K signalling: The path to discovery and understanding. Nat
Rev Mol Cell Biol. 13:195–203. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu P, Cheng H, Roberts TM and Zhao JJ:
Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev
Drug Discov. 8:627–644. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu
LJ, Kong QL, Xu LH, Zhang X, Liu WL, et al: The polycomb group
protein Bmi-1 represses the tumor suppressor PTEN and induces
epithelial-mesenchymal transition in human nasopharyngeal
epithelial cells. J Clin Invest. 119:3626–3636. 2009. View Article : Google Scholar : PubMed/NCBI
|
